Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK JOHN IRBO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.3% 16.9% 19.5% 15.1% 11.5% 8.3% 13.7% 13.5%   Credit score (0-100)   20 11 6 12 20 28 16 17   Credit rating   BB BB B BB BB BB BB BB   Credit limit (kDKK)   -0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,661 1,705 2,657 2,497 3,067 2,297 0.0 0.0   EBITDA   -28.0 -278 765 496 887 807 0.0 0.0   EBIT   -127 -379 665 434 887 807 0.0 0.0   Pre-tax profit (PTP)   -137.6 -381.0 663.1 432.5 886.3 824.5 0.0 0.0   Net earnings   -93.5 -316.8 517.2 336.5 690.5 639.2 0.0 0.0   Pre-tax profit without non-rec. items   -138 -381 663 432 886 825 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   249 163 62.4 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -810 -1,127 -610 -273 417 1,056 931 931   Interest-bearing liabilities   1,183 1,419 700 387 473 14.5 0.0 0.0   Balance sheet total (assets)   596 700 451 582 1,320 1,775 931 931   Net Debt   1,183 1,107 536 379 150 -466 -931 -931     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,661 1,705 2,657 2,497 3,067 2,297 0.0 0.0   Gross profit growth   -3.7% 2.6% 55.8% -6.0% 22.8% -25.1% -100.0% 0.0%   Employees   4 4 4 5 6 4 0 0   Employee growth %   0.0% 0.0% 0.0% 25.0% 20.0% -33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   596 700 451 582 1,320 1,775 931 931   Balance sheet change%   -31.0% 17.5% -35.6% 29.1% 126.7% 34.4% -47.5% 0.0%   Added value   -28.0 -278.1 765.5 496.0 949.3 807.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -199 -187 -202 -125 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -7.7% -22.2% 25.0% 17.4% 28.9% 35.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -8.5% -23.4% 46.0% 45.3% 81.5% 53.9% 0.0% 0.0%   ROI %   -11.3% -29.1% 62.7% 79.9% 139.0% 85.1% 0.0% 0.0%   ROE %   -12.8% -48.9% 89.9% 65.1% 138.2% 86.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -57.6% -61.7% -57.5% -31.9% 31.6% 59.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -4,225.5% -398.1% 70.0% 76.5% 16.9% -57.8% 0.0% 0.0%   Gearing %   -146.0% -125.9% -114.8% -141.5% 113.3% 1.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.9% 0.2% 0.1% 0.3% 0.1% 4.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.2 0.3 0.5 0.8 1.9 3.4 0.0 0.0   Current Ratio   0.2 0.3 0.5 0.8 1.9 3.4 0.0 0.0   Cash and cash equivalent   0.0 311.4 164.2 7.4 322.6 480.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,059.4 -1,290.3 -362.6 -155.3 622.8 1,252.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -7 -70 191 99 158 202 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -7 -70 191 99 148 202 0 0   EBIT / employee   -32 -95 166 87 148 202 0 0   Net earnings / employee   -23 -79 129 67 115 160 0 0